(1) With reference to his reply to question 1835 on 18 July 2010, (a) what are the names of the 65 antiretrovirals (ARVs) that have been registered since the inception of the backlog project and (b) which pharmaceutical company lodged the application in each case; (2) (a) how many ARV applications are still awaiting registration, (b) when was the application made in each case, (c) which pharmaceutical company made the application and (d) how many of these applications are for a combination dose ARV?